The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BLLN · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | BLLN | ONTO | LNTH | USNA |
|---|---|---|---|---|
| Moat Score (0–100) | 72 (highest) | 72 (highest) | 72 (highest) | 72 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 85 (highest) | 71 | 72 | 49 |
| Pricing power | 59 | 84 | 72 | 100 (highest) |
| Returns on capital | — | 26 | 90 | 97 (highest) |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 82 | 73 |
| Capital discipline | 44 | 80 (highest) | 46 | 40 |
| Price vs. high estimate | No price data | 535% above high estimate | 160% above high estimate | 42% below high estimate (largest discount to high estimate) |
| Market cap | $2.7B | $13.8B | $6.7B | $409.5M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |